What kind of company is DESCOVY?

IntroductionDescovy is a medication used to treat and prevent the spread of human immunodeficiency virus (HIV) infection. It is manufactured by Gilead Sciences Inc., a research-based biopharmaceutical company.

What is Descovy?Descovy is a combination drug that contains two active ingredients, emtricitabine and tenofovir alafenamide (TAF). It works by blocking the reverse transcriptase enzyme, which is necessary for the survival and replication of the HIV virus. It is prescribed for the treatment of HIV in adults and pediatric patients weighing at least 35 kg.

Descovy is also used for pre-exposure prophylaxis (PrEP), which is a preventive measure taken by some people who are at high risk of contracting HIV. The drug is used in combination with safer sex practices, such as using condoms and getting regularly tested for HIV infection.

FDA ApprovalDescovy was approved by the United States Food and Drug Administration (FDA) in 2016 for the treatment of HIV infection in adults and pediatric patients. It also received FDA approval for use in adults at high risk of contracting HIV through sexual activity in 2019.

Comparison with TruvadaTruvada is another medication used for HIV treatment and PrEP. However, it contains tenofovir disoproxil fumarate (TDF), which has been associated with bone and kidney problems in some patients. Descovy, on the other hand, contains TAF, which is a newer and safer formulation of tenofovir with fewer side effects.

ConclusionDescovy is an effective medication for the treatment and prevention of HIV infection, and it is an alternative to Truvada that offers a safer and more tolerable therapy for some patients. It is important to consult a healthcare provider for proper diagnosis and prescription of any HIV medication.